71 related articles for article (PubMed ID: 18023025)
1. Osteopontin as a molecular prognostic marker for melanoma.
Rangel J; Nosrati M; Torabian S; Shaikh L; Leong SP; Haqq C; Miller JR; Sagebiel RW; Kashani-Sabet M
Cancer; 2008 Jan; 112(1):144-50. PubMed ID: 18023025
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint inhibitors in metastatic melanoma therapy (Review).
Shah V; Panchal V; Shah A; Vyas B; Agrawal S; Bharadwaj S
Med Int (Lond); 2024; 4(2):13. PubMed ID: 38410760
[TBL] [Abstract][Full Text] [Related]
3. The Multifaceted Role of Osteopontin in Prostate Pathologies.
Silver SV; Popovics P
Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001899
[TBL] [Abstract][Full Text] [Related]
4. Increased Circulating Osteopontin Levels Promote Primary Tumour Growth, but Do Not Induce Metastasis in Melanoma.
Saup R; Nair N; Shen J; Schmaus A; Thiele W; Garvalov BK; Sleeman JP
Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189656
[TBL] [Abstract][Full Text] [Related]
5. Gene Expression Patterns of Osteopontin Isoforms and Integrins in Malignant Melanoma.
Jámbor K; Koroknai V; Kiss T; Szász I; Pikó P; Balázs M
Pathol Oncol Res; 2022; 28():1610608. PubMed ID: 36091936
[TBL] [Abstract][Full Text] [Related]
6. Protein expression of prognostic genes in primary melanoma and benign nevi.
Gambichler T; Elfering J; Meyer T; Bruckmüller S; Stockfleth E; Skrygan M; Käfferlein HU; Brüning T; Lang K; Wagener D; Schröder S; Nick M; Susok L
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2673-2680. PubMed ID: 34757537
[TBL] [Abstract][Full Text] [Related]
7. Melanoma Progression under Obesity: Focus on Adipokines.
Olszańska J; Pietraszek-Gremplewicz K; Nowak D
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34068679
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation.
Moorman HR; Poschel D; Klement JD; Lu C; Redd PS; Liu K
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33203146
[TBL] [Abstract][Full Text] [Related]
9. BET inhibitor suppresses melanoma progression
Deng G; Zeng F; Su J; Zhao S; Hu R; Zhu W; Hu S; Chen X; Yin M
Theranostics; 2020; 10(25):11428-11443. PubMed ID: 33052224
[No Abstract] [Full Text] [Related]
10.
Zhang L; Wang Q; Wang L; Xie L; An Y; Zhang G; Zhu W; Li Y; Liu Z; Zhang X; Tang P; Huo X; Guo X
Cancer Cell Int; 2020; 20():176. PubMed ID: 32467670
[TBL] [Abstract][Full Text] [Related]
11. Genetic Target Modulation Employing CRISPR/Cas9 Identifies Glyoxalase 1 as a Novel Molecular Determinant of Invasion and Metastasis in A375 Human Malignant Melanoma Cells In Vitro and In Vivo.
Jandova J; Perer J; Hua A; Snell JA; Wondrak GT
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32466621
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma.
Rizk EM; Seffens AM; Trager MH; Moore MR; Geskin LJ; Gartrell-Corrado RD; Wong W; Saenger YM
Am J Clin Dermatol; 2020 Feb; 21(1):1-11. PubMed ID: 31602560
[TBL] [Abstract][Full Text] [Related]
13. Review of diagnostic, prognostic, and predictive biomarkers in melanoma.
Ankeny JS; Labadie B; Luke J; Hsueh E; Messina J; Zager JS
Clin Exp Metastasis; 2018 Aug; 35(5-6):487-493. PubMed ID: 29722000
[TBL] [Abstract][Full Text] [Related]
14. OPN b and c Isoforms Doubtless Veto Anti-angiogenesis Effects of Curcumin in Combination with Conventional AML Regiment.
Mirzaei A; Ghaffari SH; Nikbakht M; Kamranzadeh Foumani H; Vaezi M; Mohammadi S; Alimoghaddam K; Ghavamzadeh A
Asian Pac J Cancer Prev; 2017 Sep; 18(9):2591-2599. PubMed ID: 28952709
[TBL] [Abstract][Full Text] [Related]
15. Prospective Validation of Molecular Prognostic Markers in Cutaneous Melanoma: A Correlative Analysis of E1690.
Kashani-Sabet M; Nosrati M; Miller JR; Sagebiel RW; Leong SPL; Lesniak A; Tong S; Lee SJ; Kirkwood JM
Clin Cancer Res; 2017 Nov; 23(22):6888-6892. PubMed ID: 28790109
[No Abstract] [Full Text] [Related]
16. Osteopontin b and c isoforms: Molecular Candidates Associated with Leukemic Stem Cell Chemoresistance in Acute Myeloid Leukemia.
Mirzaei A; Mohammadi S; Ghaffari SH; Nikbakht M; Bashash D; Alimoghaddam K; Ghavamzadeh A
Asian Pac J Cancer Prev; 2017 Jun; 18(6):1707-1715. PubMed ID: 28670893
[TBL] [Abstract][Full Text] [Related]
17. NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.
Guarneri C; Bevelacqua V; Polesel J; Falzone L; Cannavò PS; Spandidos DA; Malaponte G; Libra M
Oncol Rep; 2017 Feb; 37(2):737-746. PubMed ID: 28075446
[TBL] [Abstract][Full Text] [Related]
18. Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer.
Polat B; Kaiser P; Wohlleben G; Gehrke T; Scherzad A; Scheich M; Malzahn U; Fischer T; Vordermark D; Flentje M
BMC Cancer; 2017 Jan; 17(1):6. PubMed ID: 28049456
[TBL] [Abstract][Full Text] [Related]
19. Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.
Han D; Thomas DC; Zager JS; Pockaj B; White RL; Leong SP
World J Clin Oncol; 2016 Apr; 7(2):174-88. PubMed ID: 27081640
[TBL] [Abstract][Full Text] [Related]
20. Revisiting determinants of prognosis in cutaneous melanoma.
Weiss SA; Hanniford D; Hernando E; Osman I
Cancer; 2015 Dec; 121(23):4108-23. PubMed ID: 26308244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
